Drug Type Small molecule drug |
Synonyms FTX6746 |
Target |
Mechanism PPARγ modulators(Peroxisome proliferator-activated receptor γ modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization Flare Therapeutics, Inc.Startup |
Active Organization Flare Therapeutics, Inc.Startup |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC16H7ClF2N2O |
InChIKeyPCCCYEBARWZCEY-UHFFFAOYSA-N |
CAS Registry2829349-96-2 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Urogenital Neoplasms | Preclinical | US | Flare Therapeutics, Inc.Startup | 26 Oct 2022 |